| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,200 | 1,250 | 20.12. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Applied DNA Sciences, Inc.: Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA | - Regulatory Approval Showcases Clinical Advancement of Linea DNA as a Rapid and Effective Means of Producing CAR-T cell Therapies -STONY BROOK, NY / ACCESSWIRE / December 18, 2024 / Applied DNA Sciences... ► Artikel lesen | |
| Di | Applied DNA Sciences GAAP EPS of -$0.32 beats by $0.02, revenue of $0.81M misses by $0.09M | ||
| Di | Applied DNA Sciences: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines | - Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed by January 9, 2025 -- Webcast and Conference Call... ► Artikel lesen | |
| Di | APPLIED DNA SCIENCES INC - 10-K, Annual Report | ||
| Di | APPLIED DNA SCIENCES INC - 8-K, Current Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.12. | Clinical Laserthermia Systems AB: The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024. | ||
| 23.10. | Clinical Laserthermia Systems AB: CLS focus entirely on its successful neurosurgery business positioning the company for sustainable high-margin growth with a more streamlined operation | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces it will focus entirely on its successful neurosurgery business to drive sustainable high-margin growth... ► Artikel lesen | |
| 21.10. | Clinical Laserthermia Systems AB: Bulletin from the Extraordinary General Meeting on 21st of October in Clinical Laserthermia Systems AB | ||
| 09.09. | Clinical Laserthermia Systems AB: Notice of Extraordinary General Meeting at Clinical Laserthermia Systems | ||
| 19.07. | Nasdaq Stockholm AB: New equity rights for trading, Clinical Laserthermia Systems AB TO 7 B | At the request of Clinical Laserthermia Systems AB, Clinical Laserthermia
Systems AB equity rights will be traded on First North Growth Market as from
July 22, 2024.
Security name: Clinical Laserthermia... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.11. | First Andes Silver Ltd: First Andes Silver arranges $1-million financing | ||
| 29.10. | First Andes Silver Ltd.: First Andes Silver Announces High-Grade Silver Assays at Santas Gloria Property Including 0.95m at 754 g/t Ag Eq Within 7.43m at 224 g/t Ag Eq | Vancouver, British Columbia--(Newsfile Corp. - October 29, 2024) - First Andes Silver Ltd. (TSXV: FAS) (OTC Pink: MSLVF) (FSE: 9TZ0) (the "Company" or "First Andes") is pleased to announce multiple... ► Artikel lesen | |
| 11.10. | First Andes Silver Ltd: First Andes completes diamond drilling at Santas Gloria | ||
| 11.10. | First Andes Silver Ltd.: First Andes Silver Completes Initial Diamond Drill Program at Santas Gloria Silver Property | Vancouver, British Columbia--(Newsfile Corp. - October 11, 2024) - FIRST ANDES SILVER LTD. (TSXV: FAS) (OTC Pink: MSLVF) (FSE: 9TZ0) (the "Company" or "First Andes") is pleased to announce that it... ► Artikel lesen | |
| 29.07. | First Andes Silver Ltd: First Andes to begin drilling at Santas Gloria Aug. 5 |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| APPLIED DNA SCIENCES INC | 0,176 | 0,00 % |
| CLINICAL LASERTHERMIA SYSTEMS AB | 0,288 | +2,13 % |
| FIRST ANDES SILVER LTD | 0,022 | -10,42 % |
